Bayer AG (BAYN) PT Set at €124.00 by Berenberg Bank
Bayer AG (FRA:BAYN) received a €124.00 ($145.88) price objective from equities research analysts at Berenberg Bank in a research report issued on Friday. The firm currently has a “neutral” rating on the healthcare company’s stock. Berenberg Bank’s price objective would suggest a potential upside of 7.27% from the stock’s previous close.
BAYN has been the topic of several other research reports. UBS AG set a €125.00 ($147.06) price objective on Bayer AG and gave the company a “buy” rating in a report on Tuesday, August 29th. S&P Global set a €126.00 ($148.24) target price on Bayer AG and gave the stock a “buy” rating in a report on Thursday, October 26th. Independent Research GmbH set a €120.00 ($141.18) target price on Bayer AG and gave the stock a “neutral” rating in a report on Wednesday, August 23rd. equinet AG set a €118.00 ($138.82) target price on Bayer AG and gave the stock a “buy” rating in a report on Friday, October 13th. Finally, BNP Paribas set a €130.00 ($152.94) target price on Bayer AG and gave the stock a “buy” rating in a report on Monday, September 25th. Eight analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of €122.38 ($143.98).
TRADEMARK VIOLATION NOTICE: This piece of content was published by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/11/03/bayer-ag-bayn-pt-set-at-124-00-by-berenberg-bank.html.
Receive News & Ratings for Bayer AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer AG and related companies with MarketBeat.com's FREE daily email newsletter.